ESAB Corporation

ESAB

CIK 0001877322 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$721M
↑+7.5% +$50Mvs FY2024 (Q4)
Operating Income
$87M
↓-22.3% -$25Mvs FY2024 (Q4)
Net Income
$38M
↓-29.9% -$16Mvs FY2024 (Q4)
Gross Profit
$258M
↓-0.2% -$530Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
44/100
  • Profitability
    27ROIC 10.4% (10% = solid, 20%+ = moat)
  • Liquidity
    70Current Ratio 1.90 (above 1.5 = solid)
  • Leverage
    72D/E 0.57 (under 0.5 = conservative)
  • Efficiency
    34Asset Turnover 0.65x (1.0+ = capital-efficient)
  • Growth
    42Revenue YoY +7.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    20Op Margin 12.0% · trend -1.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ESAB's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

7%

Trailing 3-yr CAGR was 7.0%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$57.47
Total enterprise IV
$3.52B
Diluted shares
0.06B
Terminal PV
$2.54B (72% of total)
Year-5 FCF
$299M
YearProjected FCFDiscounted PV
+1$228M$207M
+2$244M$202M
+3$261M$196M
+4$280M$191M
+5$299M$186M
Terminal$4.09B$2.54B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$47M
investment in PP&E
Dividends paid (TTM)
$22M
cash returned to holders
Stock-based comp (TTM)
$17M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$4.77B
everything owned
Total liabilities
$2.55B
everything owed
Stockholders' equity
$2.17B
shareholder claim
Net debt
$1.05B
LT debt minus cash

Recent performance · 20 quarters

Revenue↑+7.5% +$50M
$721M
Net Income↓-29.9% -$16M
$38M
Free Cash Flow↓-24.2% -$25M
$77M
Operating Margin↓-4.6pts
12.0%

Drill down